2013
DOI: 10.1007/s10072-013-1603-6
|View full text |Cite
|
Sign up to set email alerts
|

Antinociceptive effect of matrine on vincristine-induced neuropathic pain model in mice

Abstract: Chemotherapy drugs treatment causes neuropathic pain, hyperalgesia and allodynia are common components of neuropathic pain, so effectively therapeutic strategy is required. In this study, we evaluated the antinociceptive effects of matrine on vincristine-induced neuropathic pain in mice. Vincristine (100 μg/kg i.p.) was administered once per day for 7 days (day 0-6) in mice. Matrine (15, 30, 60 mg/kg, i.p.) was repeated administration in early phase (day 0-6) or late phase (day 7-13). Hyperalgesia and allodyni… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(10 citation statements)
references
References 29 publications
0
10
0
Order By: Relevance
“…Studies have shown that MT (15-60 mg/kg, i.p.) had an anti-nociceptive effect on mechanical stimulation and cold stimulation of vincristine induced neuropathic pain in model mice (Dun L. L. et al, 2014). In addition, it has been shown that MT reduced vincristine-induced neuropathic pain in mice through mechanisms associated with down-regulation of expression of spinal cord Ras, phosphorylated c-Raf, p-ERK 1/2, TNF-a, and IL -6, and upregulation of the expression of IL-10 (Gong et al, 2016).…”
Section: Anti-nociceptive Activitymentioning
confidence: 97%
“…Studies have shown that MT (15-60 mg/kg, i.p.) had an anti-nociceptive effect on mechanical stimulation and cold stimulation of vincristine induced neuropathic pain in model mice (Dun L. L. et al, 2014). In addition, it has been shown that MT reduced vincristine-induced neuropathic pain in mice through mechanisms associated with down-regulation of expression of spinal cord Ras, phosphorylated c-Raf, p-ERK 1/2, TNF-a, and IL -6, and upregulation of the expression of IL-10 (Gong et al, 2016).…”
Section: Anti-nociceptive Activitymentioning
confidence: 97%
“…In a mouse model for squamous cell carcinoma, matrine was administered at a dosage of 250 g/kg with no apparent adverse impact on health (49). Furthermore, it has been reported that matrine could ease the pain of cancer patients receiving chemotherapy, enhance the body's immunity and protect major organs such as the heart, liver and kidney from being damaged by chemicals/drugs during chemotherapy (50)(51)(52), all of which could help improve the quality of life of lung cancer patients receiving chemotherapy.…”
Section: Discussionmentioning
confidence: 99%
“…In fact, the biological activities of matrine are more relevant to other applications of Ku-Shen other than anti-tumor activities. It is reported to possess a variety of pharmacological activities, including antipyretic ( Cho et al, 1986 ; Xiang and Jiang, 2013 ), antiepileptic ( Xiang and Jiang, 2013 ), antinociceptive ( Wang et al, 2013 ; Dun et al, 2014 ), anti-inflammatory ( Zhang B. et al, 2011 ; Wu G. et al, 2017 ), myocardial preservation ( Zhang et al, 2006 ), antifibrotic ( Zhang et al, 2001 ), anti-tumor ( Wu J. et al, 2017 ), anti-viral ( Li et al, 2005 ) and anti-angiogenic ( Li et al, 2010 ). Our predicted results demonstrated that matrine could target a molecular network related to multiple functions, which is consistent with the multi-target nature of traditional medicine.…”
Section: Discussionmentioning
confidence: 99%